Xencor (XNCR) Accumulated Expenses (2013 - 2026)
Xencor's (XNCR) quarterly Accumulated Expenses came in at $34.3 million in Q1 2026, up 113.24% year-on-year from $16.1 million in Q1 2025, and down 2.02% on a QoQ basis from $35.0 million in Q4 2025.
Xencor (XNCR) Accumulated Expenses (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Accumulated Expenses data on file, last reported at $34.3 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses rose 113.24% year-over-year to $34.3 million in Q1 2026; TTM through Mar 2026 was $34.3 million, a 113.24% increase from a year earlier, with the FY2025 full-year figure at $35.0 million, up 81.92% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $34.3 million, down from $35.0 million in the prior quarter.
- Over the last five years, Accumulated Expenses for XNCR reached as high as $35.0 million in Q4 2025 and fell as low as $12.6 million in Q1 2022.
- Historically, Accumulated Expenses has averaged $21.4 million across 5 years, with a median of $19.3 million in 2022.
- Across the five-year window, Accumulated Expenses decreased 18.45% in 2024 and surged 113.24% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $18.7 million in 2022, then grew by 25.82% to $23.6 million in 2023, then decreased by 18.45% to $19.2 million in 2024, then soared by 81.92% to $35.0 million in 2025, then retreated by 2.02% to $34.3 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $34.3 million in Q1 2026, $35.0 million in Q4 2025, and $28.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.25 Mn |
| Dec 31, 2025 | 34.96 Mn |
| Sep 30, 2025 | 28.11 Mn |
| Jun 30, 2025 | 23.88 Mn |
| Mar 31, 2025 | 16.06 Mn |
| Dec 31, 2024 | 19.22 Mn |
| Sep 30, 2024 | 25.41 Mn |
| Jun 30, 2024 | 19.56 Mn |
| Mar 31, 2024 | 13.49 Mn |
| Dec 31, 2023 | 23.56 Mn |
| Sep 30, 2023 | 24.47 Mn |
| Jun 30, 2023 | 18.44 Mn |
| Mar 31, 2023 | 15.14 Mn |
| Dec 31, 2022 | 18.73 Mn |
| Sep 30, 2022 | 19.29 Mn |
| Jun 30, 2022 | 16.35 Mn |
| Mar 31, 2022 | 12.61 Mn |
| Dec 31, 2021 | 19.44 Mn |
| Sep 30, 2021 | 22.11 Mn |
| Jun 30, 2021 | 17.33 Mn |